| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.04 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.37 | 0.04 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |